天士力：全资子公司药品硫酸氨基葡萄糖胶囊获得药品注册证书

Core Viewpoint - Tianjin Tianshili's wholly-owned subsidiary, Tianshili Shente, has received a drug registration certificate for Glucosamine Sulfate Capsules from the National Medical Products Administration, indicating a significant regulatory approval for a product aimed at treating primary and secondary osteoarthritis [1] Company Summary - The drug registration certificate for Glucosamine Sulfate Capsules is a key milestone for Tianjin Tianshili, enhancing its product portfolio in the pharmaceutical sector [1] - The indication for the drug is specifically for primary and secondary osteoarthritis, which addresses a significant market need [1]